The Cost-Effectiveness of Tenofovir Alafenamide for Chronic Hepatitis B Virus in Taiwan

The Cost-Effectiveness of Tenofovir Alafenamide for Chronic Hepatitis B Virus in Taiwan

Background. Chronic hepatitis B (CHB) is a lifelong disease requiring long-term or indefinite therapy, resulting in substantial economic burden. Thus, careful consideration must be used in the selection of therapies. Aim. This analysis assessed the cost-effectiveness of tenofovir alafenamide (TAF) c...

Full description

Saved in:
Bibliographic Details
Main Authors: Elise Chia-Hui Tan, Alon Yehoshua, Sushanth Jeyakumar, Pongo Peng, Amy Lin, Nathaniel J. Smith, Nandita Kachru
Format: Article
Language:English
Published: SAGE Publishing 2025-03-01
Series:MDM Policy & Practice
Online Access:https://doi.org/10.1177/23814683251328659
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items